CN114209056A - American ginseng and cervus elaphus linnaeus capsules - Google Patents
American ginseng and cervus elaphus linnaeus capsules Download PDFInfo
- Publication number
- CN114209056A CN114209056A CN202111583870.2A CN202111583870A CN114209056A CN 114209056 A CN114209056 A CN 114209056A CN 202111583870 A CN202111583870 A CN 202111583870A CN 114209056 A CN114209056 A CN 114209056A
- Authority
- CN
- China
- Prior art keywords
- american ginseng
- cervus elaphus
- elaphus linnaeus
- powder
- resisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000005373 Panax quinquefolius Species 0.000 title claims abstract description 35
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 35
- 241000283026 Cervus elaphus Species 0.000 title claims abstract description 18
- 239000002775 capsule Substances 0.000 title claims abstract description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229920002261 Corn starch Polymers 0.000 claims abstract description 7
- 239000008120 corn starch Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 4
- 210000003056 antler Anatomy 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 9
- 239000011812 mixed powder Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000011265 semifinished product Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 230000002107 myocardial effect Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 206010002660 Anoxia Diseases 0.000 abstract description 2
- 241000976983 Anoxia Species 0.000 abstract description 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 2
- 206010019280 Heart failures Diseases 0.000 abstract description 2
- 206010021143 Hypoxia Diseases 0.000 abstract description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 abstract description 2
- 102000007072 Nerve Growth Factors Human genes 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 230000007953 anoxia Effects 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 210000003169 central nervous system Anatomy 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 210000004351 coronary vessel Anatomy 0.000 abstract description 2
- 230000035619 diuresis Effects 0.000 abstract description 2
- 230000005284 excitation Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 230000036284 oxygen consumption Effects 0.000 abstract description 2
- 229930182490 saponin Natural products 0.000 abstract description 2
- 150000007949 saponins Chemical class 0.000 abstract description 2
- 235000017709 saponins Nutrition 0.000 abstract description 2
- 230000035939 shock Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003337 fertilizer Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010068975 Bone atrophy Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000001651 autotrophic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides an American ginseng cervus elaphus linnaeus capsule, belonging to the field of nourishing health care products; the compound fertilizer is prepared from the following raw materials: 0.15g of American ginseng, 0.13g of cervus elaphus linnaeus, 0.01g of corn starch and 0.01g of magnesium stearate. The American ginseng and cervus elaphus linnaeus capsule has an inhibition effect on a central nervous system, has an excitation box protection effect on the living pivots, has a function of enhancing nerve growth factors, and produces an inhibition effect, wherein American ginseng total saponins have the effects of resisting fatigue, resisting anoxia, resisting diuresis, resisting stress and shock, increasing myocardial blood flow, reducing coronary artery assistance, reducing myocardial oxygen consumption, reducing blood sugar, and treating coronary heart disease, heart failure and cardiovascular diseases.
Description
Technical Field
The invention relates to the field of nourishing health care products, in particular to an American ginseng cervus elaphus linnaeus capsule.
Background
American ginseng is sweet, slightly bitter and cool in nature; it belongs to lung, heart, kidney and spleen channels, has effects of invigorating qi, nourishing yin, clearing heat and promoting fluid production, and is mainly used for treating qi and yin injury, lung qi deficiency and lung yin deficiency.
Hairy antler, also known as antler, eastern hairy antler and western hairy antler, of the cervidae, mainly inhabits mountain forest grassland. According to the shape of antler, hairy antler can be divided into lotus antler, three-twig antler and four-twig antler. Has effects in invigorating kidney yang, nourishing essence and blood, strengthening tendons and bones, regulating Chong and ren meridians, and relieving sore. Can be used for treating sexual impotence, spermatorrhea, infertility due to cold womb, emaciation, listlessness, aversion to cold, vertigo, tinnitus, deafness, lumbago, muscle and bone atrophy, metrorrhagia, leukorrhagia, and dorsal furuncle.
At present, most of middle-aged and elderly people are in a sub-health state and are accompanied by body weakness, and the pilose antler is the best deficiency tonifying product, but is not suitable for being directly eaten by the old people with hypertension.
Disclosure of Invention
Aiming at the technical defects, the invention aims to provide an American ginseng and cervus elaphus linnaeus capsule.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides an American ginseng cervus elaphus linnaeus capsule which is prepared from the following raw materials: 0.15g of American ginseng, 0.13g of cervus elaphus linnaeus, 0.01g of corn starch and 0.01g of magnesium stearate.
A preparation method of American ginseng and cervus elaphus linnaeus capsules comprises the following steps:
step 1, firstly selecting more than five years of American ginseng, cleaning, drying in the sun, slicing, drying, sterilizing and crushing to obtain American ginseng powder;
step 2, carrying out freeze-drying treatment on the pilose antler, then carrying out unhairing treatment by using a blade, and then carrying out slicing, drying, sterilizing and crushing treatment on the pilose antler to obtain pilose antler powder;
step 3, mixing the crushed American ginseng powder and the crushed pilose antler powder, and adding corn starch and magnesium duranate in the crushing process until the mixture is uniformly mixed to obtain semi-finished product powder;
and 4, encapsulating and packaging the mixed powder, and selling the mixed powder on the market.
Specifically, American ginseng needs to be detected for pesticide residues, and the detection result is ensured to be within the national allowable range.
Specifically, the sliced American ginseng is dried at 100 ℃, sterilized by ultraviolet rays, and then is subjected to superfine grinding in a sterile room, wherein the grinding standard is 300-400 meshes, so that the American ginseng is convenient for human body absorption.
Specifically, cornu Cervi Pantotrichum may be replaced by common cornu Cervi Pantotrichum, and the cornu Cervi Pantotrichum is autotrophic cornu Cervi Pantotrichum or purchased cornu Cervi Pantotrichum.
Specifically, the sliced pilose antler is irradiated and sterilized by ultraviolet rays and sent into a clean room for ultramicro crushing, wherein the crushing standard is 300-400 meshes, and the aim is to facilitate absorption by a human body.
Specifically, all the processes of bagging are carried out in a GMP workshop.
Specifically, the American ginseng and cervus elaphus linnaeus capsules are subjected to three tests:
1. raw material inspection, mainly including components and bacteria.
2. And (5) checking a semi-finished product, wherein the semi-finished product mainly contains bacteria.
3. The main detection components are bacteria, powder and ash.
And after all the products reach the standard, the products enter a shady and cool warehouse for storage and delivery.
The invention has the beneficial effects that:
the American ginseng and cervus elaphus linnaeus capsule has an inhibition effect on a central nervous system, has an excitation box protection effect on the living pivots, has a function of enhancing nerve growth factors, and produces an inhibition effect, wherein American ginseng total saponins have the effects of resisting fatigue, resisting anoxia, resisting diuresis, resisting stress and shock, increasing myocardial blood flow, reducing coronary artery assistance, reducing myocardial oxygen consumption, reducing blood sugar, and treating coronary heart disease, heart failure and cardiovascular diseases.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The American ginseng and cervus elaphus linnaeus capsule is prepared from the following raw materials: 0.15g of American ginseng, 0.13g of cervus elaphus linnaeus, 0.01g of corn starch and 0.01g of magnesium stearate.
A preparation method of American ginseng and cervus elaphus linnaeus capsules comprises the following steps:
step 1, firstly selecting more than five years of American ginseng, cleaning, drying in the sun, slicing, drying, sterilizing and crushing to obtain American ginseng powder;
step 2, carrying out freeze-drying treatment on the pilose antler, then carrying out unhairing treatment by using a blade, and then carrying out slicing, drying, sterilizing and crushing treatment on the pilose antler to obtain pilose antler powder;
step 3, mixing the crushed American ginseng powder and the crushed pilose antler powder, and adding corn starch and magnesium duranate in the crushing process until the mixture is uniformly mixed to obtain semi-finished product powder;
and 4, encapsulating and packaging the mixed powder, and selling the mixed powder on the market.
American ginseng is cold in nature, enters heart, lung and kidney channels, invigorates qi and nourishes yin, clears fire and promotes the production of body fluid.
Lu Rong is warm in nature, enters liver and kidney meridians, and has the actions of tonifying kidney yang, nourishing essence and blood, strengthening tendons and bones, regulating Chong and ren meridians, and relieving sore toxicity.
Lu Rong is a kind of meat-blood with emotion, and good at tonifying kidney yang, benefiting essence and blood, and is a medicine for tonifying yang, fatigue, replenishing essence and filling marrow, and it is good at treating kidney yang deficiency, impotence, spermatorrhea, seminal emission, soreness and weakness of waist and knees, muscle and bone weakness, dizziness and tinnitus, lassitude and so on. For various diseases of insufficiency of essence and blood, the medicine has the functions of warming kidney and strengthening yang, tonifying essence and blood, strengthening bones and muscles, and for deficiency of liver and kidney and deficiency of both essence and blood. All of them are combined with each other to strengthen the body resistance and build up the foundation, because of their deficiency, dizziness, blurred vision, and sallow face.
Specifically, the American ginseng is negative in performance, has the effects of promoting the production of body fluid to quench thirst, tonifying kidney, benefiting essence and blood, strengthening muscles and bones according to the warm nature of the pilose antler, generates neutrality according to the theory of traditional Chinese medicine, has the effects of warming and invigorating kidney yang, preventing imbalance of yin and yang, enhancing immunity and improving the power of resistance, and is edible for treating hyperglycemia, hyperlipidemia, heart disease and constitution and early recovery of a large disease.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (2)
1. The American ginseng and cervus elaphus linnaeus capsule is characterized by being prepared from the following raw materials: 0.15g of American ginseng, 0.13g of cervus elaphus linnaeus, 0.01g of corn starch and 0.01g of magnesium stearate.
2. The American ginseng cervus elaphus linnaeus capsule as claimed in claim 1, wherein the preparation method comprises the following steps:
step 1, firstly selecting more than five years of American ginseng, cleaning, drying in the sun, slicing, drying, sterilizing and crushing to obtain American ginseng powder;
step 2, carrying out freeze-drying treatment on the pilose antler, then carrying out unhairing treatment by using a blade, and then carrying out slicing, drying, sterilizing and crushing treatment on the pilose antler to obtain pilose antler powder;
step 3, mixing the crushed American ginseng powder and the crushed pilose antler powder, and adding corn starch and magnesium duranate in the crushing process until the mixture is uniformly mixed to obtain semi-finished product powder;
and 4, encapsulating and packaging the mixed powder, and selling the mixed powder on the market.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111583870.2A CN114209056A (en) | 2021-12-22 | 2021-12-22 | American ginseng and cervus elaphus linnaeus capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111583870.2A CN114209056A (en) | 2021-12-22 | 2021-12-22 | American ginseng and cervus elaphus linnaeus capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114209056A true CN114209056A (en) | 2022-03-22 |
Family
ID=80705346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111583870.2A Pending CN114209056A (en) | 2021-12-22 | 2021-12-22 | American ginseng and cervus elaphus linnaeus capsules |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114209056A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107744564A (en) * | 2016-08-10 | 2018-03-02 | 杨丛刚 | A kind of benefiting qi and nourishing blood, the antler health-care product of strengthen immunity and preparation technology |
| CN108096418A (en) * | 2017-12-21 | 2018-06-01 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of American Ginseng Gingkocapsule |
| CN108553493A (en) * | 2018-06-11 | 2018-09-21 | 广东省阳春市信德生物科技发展有限公司 | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula |
-
2021
- 2021-12-22 CN CN202111583870.2A patent/CN114209056A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107744564A (en) * | 2016-08-10 | 2018-03-02 | 杨丛刚 | A kind of benefiting qi and nourishing blood, the antler health-care product of strengthen immunity and preparation technology |
| CN108096418A (en) * | 2017-12-21 | 2018-06-01 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of American Ginseng Gingkocapsule |
| CN108553493A (en) * | 2018-06-11 | 2018-09-21 | 广东省阳春市信德生物科技发展有限公司 | A kind of ganoderma lucidum American Ginseng cervus elaphus linnaeus capsule formula |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103525641A (en) | Health-care wine and preparation method thereof | |
| CN104288495A (en) | Chinese yam-rhizoma polygonati capsule and preparation method thereof | |
| CN107319086A (en) | A kind of matrimony vine spun gold emperor chrysanthemum pressed candy and preparation method thereof | |
| CN102145042A (en) | Eucommia wine | |
| CN112316053A (en) | Deer penis honey cream | |
| CN102370943A (en) | Chinese herbal medicine used for treating neurasthenia | |
| CN104663952A (en) | Anti-aging cynomorium songaricum tea and preparation method thereof | |
| CN110859904A (en) | Gorgon fruit oral liquid capable of tonifying kidney, supporting yang, tonifying qi and producing sperm | |
| CN111423963A (en) | Medicinal and edible essence-medlar wine and preparation method thereof | |
| CN114209056A (en) | American ginseng and cervus elaphus linnaeus capsules | |
| CN102145118A (en) | Morinda officinalis wine | |
| CN103599409B (en) | One treats prosopalgic Chinese medicine composition | |
| CN107349387A (en) | A kind of Traditional Chinese medicine foot bath bag of nourishing yin and nourishing blood and preparation method thereof | |
| CN103751301B (en) | For the goods of aseptic necrosis of femoral head patient | |
| CN113974162A (en) | Chinese pear syrup cubilose and preparation method thereof | |
| CN111544529A (en) | Traditional Chinese medicine composition for nourishing heart and soothing nerves | |
| CN108186739A (en) | It is a kind of to be used to correct Chinese medicine preparation of nearly amblyopia and preparation method thereof | |
| CN104026663A (en) | Rhizoma nardostachyos soup with functions of enlivening spleen and strengthening stomach and production method thereof | |
| CN107890558A (en) | A kind of Chinese medicine composition for treating infantile diarrhea and preparation method thereof | |
| CN100479844C (en) | Method for preparing kidney-nourshing health-preserving oral liquid containing micron pine pollen, deer antler powder, tortoise plastron powder, curculigo rhizome powder, walnut powder, dried solomo | |
| CN116326768A (en) | Ginseng and antler capsule | |
| CN118680970A (en) | Refreshing and anti-aging traditional Chinese medicine and preparation method thereof | |
| CN103815326A (en) | Polygala tenuifolia mind-tranquilizing and nerve-soothing hot-pot condiment and preparation method | |
| CN117180389A (en) | Traditional Chinese medicine composition for treating bone injury | |
| CN112057473A (en) | Composition for enhancing lung capacity and lung diseases and lung cancer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220322 |
|
| RJ01 | Rejection of invention patent application after publication |